DE69732363D1 - HUMANES THYMOSIN beta 15 GEN,PROTEIN UND DESSEN VERWENDUNGEN - Google Patents

HUMANES THYMOSIN beta 15 GEN,PROTEIN UND DESSEN VERWENDUNGEN

Info

Publication number
DE69732363D1
DE69732363D1 DE69732363T DE69732363T DE69732363D1 DE 69732363 D1 DE69732363 D1 DE 69732363D1 DE 69732363 T DE69732363 T DE 69732363T DE 69732363 T DE69732363 T DE 69732363T DE 69732363 D1 DE69732363 D1 DE 69732363D1
Authority
DE
Germany
Prior art keywords
thymosin beta
protein
humanese
gen
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69732363T
Other languages
English (en)
Other versions
DE69732363T2 (de
Inventor
R Zetter
Lere Bao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Application granted granted Critical
Publication of DE69732363D1 publication Critical patent/DE69732363D1/de
Publication of DE69732363T2 publication Critical patent/DE69732363T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69732363T 1996-06-17 1997-06-13 HUMANES THYMOSIN beta 15 GEN,PROTEIN UND DESSEN VERWENDUNGEN Expired - Fee Related DE69732363T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US664856 1996-06-17
US08/664,856 US5663071A (en) 1996-06-17 1996-06-17 Human thymosin β 15 gene, protein and uses thereof
PCT/US1997/010315 WO1997048805A1 (en) 1996-06-17 1997-06-13 HUMAN THYMOSIN β15 GENE, PROTEIN AND USES THEREOF

Publications (2)

Publication Number Publication Date
DE69732363D1 true DE69732363D1 (de) 2005-03-03
DE69732363T2 DE69732363T2 (de) 2005-12-22

Family

ID=24667732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69732363T Expired - Fee Related DE69732363T2 (de) 1996-06-17 1997-06-13 HUMANES THYMOSIN beta 15 GEN,PROTEIN UND DESSEN VERWENDUNGEN

Country Status (9)

Country Link
US (2) US5663071A (de)
EP (1) EP0934412B1 (de)
JP (1) JP2000516086A (de)
AT (1) ATE287952T1 (de)
AU (1) AU732707B2 (de)
CA (1) CA2257855A1 (de)
DE (1) DE69732363T2 (de)
ES (1) ES2236813T3 (de)
WO (1) WO1997048805A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831033A (en) * 1997-02-14 1998-11-03 Children's Medical Center Of Boston Human thymosin β15 gene, protein and uses thereof
AU1085099A (en) * 1997-10-16 1999-05-03 Children's Medical Center Corporation Thymosin beta15 promoter and use thereof
US6218122B1 (en) * 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
US20070191275A1 (en) * 1998-07-30 2007-08-16 Regenerx Biopharmaceuticals, Inc. Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments
ATE292473T1 (de) * 1998-07-30 2005-04-15 Us Gov Health & Human Serv Thymosin beta 4 stimuliert wundheilung
US20040067227A1 (en) * 2001-11-02 2004-04-08 Goldstein Allan L. Inhibition or reversal of skin aging by actin-sequestering peptides
US20060100156A1 (en) * 2004-10-01 2006-05-11 Regenerx Biopharmaceuticals, Inc. Cell nucleus-entering compositions
US20070015698A1 (en) * 1998-07-30 2007-01-18 United States Of America As Represented By The Secretary Of Health Treatment of skin, and wound repair, with thymosin beta 4
US20080096817A1 (en) * 1998-07-30 2008-04-24 Regenerx Biopharmaceuticals, Inc. METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (Tbeta4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
US6642009B2 (en) 1999-05-17 2003-11-04 Cytyc Health Corporation Isolated ductal fluid sample
CN101549148A (zh) 2001-08-29 2009-10-07 雷根内克斯生物制药有限公司 多肽在制备用于促进心内膜细胞向间质细胞转化的药物中的应用
WO2007027578A2 (en) * 2005-08-31 2007-03-08 Regenerx Biopharmaceuticals, Inc. Methods and compositions for decreasing cohesivity of pathological respiratory tract secretions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0121912A1 (de) * 1983-04-07 1984-10-17 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Radioimmunverfahren zur Bestimmung von Thymosin-beta-4

Also Published As

Publication number Publication date
US5663071A (en) 1997-09-02
US5721337A (en) 1998-02-24
WO1997048805A1 (en) 1997-12-24
AU3392597A (en) 1998-01-07
JP2000516086A (ja) 2000-12-05
ATE287952T1 (de) 2005-02-15
DE69732363T2 (de) 2005-12-22
EP0934412B1 (de) 2005-01-26
EP0934412A1 (de) 1999-08-11
AU732707B2 (en) 2001-04-26
ES2236813T3 (es) 2005-07-16
CA2257855A1 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
Wilkinson Troponin C from rabbit slow skeletal and cardiac muscle is the product of a single gene
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
IL141021A (en) Use of copolymer-like polypeptide-1 to prepare a drug to treat autoimmune diseases
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
DE69732363D1 (de) HUMANES THYMOSIN beta 15 GEN,PROTEIN UND DESSEN VERWENDUNGEN
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
DK0922223T3 (da) Fremgangsmåde til prognosticering af cancer
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
MY104909A (en) Peptide compounds.
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
HUP9900789A2 (hu) Lefelé irányuló szabályozásra rezisztens C3 konvertáz
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
WO2001098355A3 (en) Cgi-69 compositions and methods of use
BG105682A (en) Bone stimulating factor
DE69529235D1 (de) Menschliche dnase i varianten
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
EP0292302A3 (de) Menschliches Splenin
NZ509284A (en) Tumour antigen peptide derived from SART-that binds to HLA-A24 antigen thereby facilitating recognition by a T call
EA199900432A1 (ru) Ice-ингибирующие пептиды
MX9706429A (es) Variantes de dnasa i humana.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee